secwatch.observer — SEC 8-K summary
======================================

Issuer:     GLAUKOS Corp (GKOS)
CIK:        0001192448
Form:       8-K
Filed at:   2025-02-20T23:59:59+00:00
Accession:  0001558370-25-001217
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Glaukos Q4 record net sales $105.5M, +28% YoY; guides FY2025 $475-485M
----------------------------------------------------------------------

- Q4 net sales record $105.5M, +28% YoY; glaucoma segment $84.1M (+39%).
- GAAP net loss ($0.60)/share vs ($0.75) prior year; non-GAAP net loss ($0.40).
- FY 2024 net sales $383.5M (+22% YoY); net loss $146.4M ($2.77/share).
- Cash $324M, no debt; 2025 revenue guidance $475-485M.
- Q4 GAAP gross margin 73%; non-GAAP gross margin 82%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1192448/000155837025001217/0001558370-25-001217-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1192448/000155837025001217/gkos-20250220x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-25-001217

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer